Text message support for Latino caregivers of Alzheimer's patients
Official title: Testing the Effects of a Text Message Caregiver Support Intervention for Latinos
Run by University of Kansas Medical Center · NCT06728436 · Data updated 2026-11-12
This study tests if a text messaging program can help Latino caregivers of Alzheimer's patients feel less stressed and more supported compared to regular care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 288 (estimated) |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Fairway, Kansas) |
| Status | Recruiting |
| Started | February 17, 2025 |
| Main results expected | May 2029 |
| Study ends | May 2029 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT06728436 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Latino caregivers over 18 who provide hands-on care for a relative diagnosed with Alzheimer's disease and experience depressive symptoms.
✕Probably not a fit
Patients who are not caregivers for someone with Alzheimer's disease or who are already participating in another similar intervention may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of CuidaTEXT, a text messaging intervention designed to support Latino caregivers of individuals with Alzheimer's disease and related dementias. Participants will be randomly assigned to receive either the CuidaTEXT intervention or standard care, allowing researchers to assess the impact on caregiver stress and related outcomes. The intervention includes a variety of text messages focused on education, social support, self-care, and care management. Participants will also complete assessments regarding their mental health and caregiving preparedness.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce caregiver stress and improve the well-being of Latino caregivers.
How similar studies have gone: Other studies have shown positive outcomes with text message interventions for caregiver support, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over the age of 18 * Spanish and English-speaking people who identify as Latino * Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment * Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10) * Self-reports being able to read and write * Owns a cell phone with a flat fee, and uses it at least weekly for texting. Exclusion Criteria: * Participation in another wellbeing-related clinical trial * Cohabitation with another participant in the CuidaTEXT R01 Study * Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study * Participant plans to move to another country within seven months
Where it's running
-
University of Kansas Medical Center
Fairway, Kansas, United States Recruiting
Study contacts
- Principal investigator: Jaime Perales Puchalt, PhD, MPH — University of Kansas Medical Center
- Study coordinator: Rachel Ruiz
- Email: rruiz3@kumc.edu
- Phone: 913-945-5052
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Mild Alzheimer's Dementia
This study will test whether a low-dose brain radiation treatment using HeLaXON helps people with mild Alzheimer's dementia improve or stabilize thinking and daily function.
-
Cervical lymphatic surgery to see if it helps people with mild Alzheimer’s
We’re testing a surgical approach in people with mild Alzheimer’s to see if creating alternative neck lymph drainage routes can affect brain biomarkers and daily function.
-
Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease
This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.
-
Testing LY4405094 in healthy people and people with Alzheimer’s disease
This study tests LY4405094 to see if it is safe and how it behaves in the body, including how it reaches the brain fluid in healthy participants and how it affects a brain protein in people with Alzheimer's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.